chlorpheniramine maleate; pseudoephedrine hydrochloride
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE (chlorpheniramine maleate; pseudoephedrine hydrochloride) by Ascentage Pharma. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1988.
Drug data last refreshed 21h ago · AI intelligence enriched 6d ago
Pseudoephedrine hydrochloride and chlorpheniramine maleate is a combination oral capsule containing a decongestant and first-generation antihistamine. It treats upper respiratory allergy symptoms including runny nose, itchy/watery eyes, sneezing, and throat itching due to hay fever and other allergies. The decongestant reduces nasal congestion while the antihistamine blocks histamine-mediated allergic responses.
Product is approaching loss of exclusivity with high competitive pressure (30/100), signaling transition planning and likely smaller, focused brand teams managing decline or generic transition.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on this product offers limited career growth opportunities given its LOE status and zero linked job openings. Roles are primarily defensive, focused on managing market decline, protecting remaining market share, and transitioning to generics or portfolio consolidation.